Edwards Lifesciences 1st-qtr net profit falls, sales rise 5 pct
April 24 (Reuters) - Medical device maker Edwards Lifesciences Corp said on Thursday quarterly net earnings fell due to higher manufacturing costs, unfavorable foreign exchange rates and a year-earlier gain of $83.6 million related to patent litigation.
The medical device maker said first-quarter net income dropped to $60.3 million, or 56 cents a share, from $143.9 million, or $1.24 a share, a year earlier.
Excluding special items, Edwards said it earned 76 cents a share.
Quarterly net sales rose 5.2 percent to $522.4 million.
For the full year, Edwards said it still expects sales of $2.05 billion to $2.25 billion. The company projected second-quarter adjusted earnings per share of 71 to 81 cents on sales of $525 million to $565 million.
(Reporting by Deena Beasley in Los Angeles; editing by Matthew Lewis)
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video